Practical lessons for publishers

Putting patients first For decades, research publishing followed a fixed script. Researchers investigated. Publishers validated, polished and shared their findings. Patients, if mentioned, were the subjects of the research, not contributors to it. That model is shifting. Across the publishing industry, there’s growing recognition that ...

Most US neurologists prescribing MS drugs have received pharma industry cash

Higher volume prescribers more likely to receive payments; and recipients more likely to prescribe that company’s drugs, especially if payments were larger, sustained, and recent Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to ...

2025-08-26T10:41:57+00:0026 August 2025|BMJ Open, Press release|

Companies may be misleading parents with “outrageous claims” about banking baby teeth

Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...

2025-08-26T10:24:27+00:0026 August 2025|Press release, The BMJ|

Youth vaping consistently linked to subsequent smoking, marijuana and alcohol use

As well as heightened risks of asthma, cough, injuries and mental ill health + possibly pneumonia, bronchitis, headaches, migraines, dizziness, low sperm count, poor oral health Vaping among teens and young people is consistently linked to subsequent smoking, marijuana and alcohol use, finds an overarching (umbrella) review of systematic reviews ...

2025-08-20T13:32:55+00:0020 August 2025|Press release, Tobacco Control|

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks ...

2025-08-20T12:17:44+00:0020 August 2025|Journal of Medical Ethics, Press release|

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

2025-08-15T14:49:00+00:0015 August 2025|Press release, The BMJ|
Go to Top